Navigation Links
Anti-rejection Therapy a Boon for Patients With "anti-donor" Antibody Levels

Soraya Kohanzadeh, 30, Muir Beach, CA, was living day-to-day, extremely ill, with no hope and expecting to live a shortened life dependent// on kidney dialysis. She needed a kidney transplant but because her “anti-donor” antibody levels were so high, her doctors believed that a transplant was not possible – perhaps ever.

However, thanks to a specialized type of anti-rejection therapy pioneered at Cedars-Sinai Medical Center, Soraya successfully underwent a transplant in May of this year and has a “new lease on life” as she looks forward to 2007.

Soraya, was among the estimated 33 percent of kidney failure patients who have high “anti-donor” antibody levels and who are often told that a transplant is not possible even if a potential donor’s tissue and blood types otherwise match perfectly.

But on May 16, 2006, she received a kidney donated by her mother, Joan Lando, at Cedars-Sinai. The transplanted kidney started working immediately, both patients recovered well, and Soraya has had no episodes of rejection – the result of a therapy that makes the incompatible compatible and the impossible a reality in many cases.

Soraya had expected to live a shortened life, dependent on kidney dialysis -- a painful, expensive, time-consuming procedure that cleans blood well enough to maintain existence but not well enough to contribute to quality of life.

Physicians in the San Francisco area said transplantation was not an option because a donor organ would be rejected by her hyper-vigilant immune system – a prospect faced by about one-third of the more than 70,000 patients on the nation’s kidney transplant waiting lists. But Soraya conducted an Internet search and found that Cedars-Sinai is one of the very few centers in the nation addressing this problem.

Tissue compatibility issues exist for all patients receiving transplanted organs, but rejection risks are dramatically increased for those with high exposur
'"/>




Page: 1 2 3 4

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis

Post Your Comments:
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...stCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ONXX )...ntsinDecember: ,, ASHBriefing ,, Decem...investigatorswilldiscussdatapresentationssurroundi...loma,asfeaturedatthe51stAmericanSocietyofHematolog...eteleconferencewillbeginat9:00a.m.CT/10:00a.m.ETon...
(Date:11/25/2009).../--TheBlackAIDSInstituterecentlyheldBoardofDirecto..., ThenewBoardMembersareahighlydiversegroupoflea...rnmenthealthprograms,editorial,andbusinessentrepre...backgroundsincludingbothheterosexualandgayBlackmen...ngmultipleagegroups. ,, (Photo: http://www.news...
(Date:11/25/2009)...ollaboration between UCLA engineers and physicians...lion Americans who suffer from peripheral arterial...rteries, peripheral arterial disease, or PAD, is a...ries reduce blood flow to the limbs. The condition...art attack and stroke, and its progression can res...
(Date:11/25/2009)...erlook needed care, study finds , , WEDN...ession can worsen her child,s asthma, U.S. researc... black mothers and their children found that child... more frequent asthma symptoms, while children of ...equent asthma symptoms. , The Johns Hopkins Chi...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
..., Calif., Feb. 12 Fisher Vista, LLC, a marketing,...or care and human resource,industries today announ...pany,for seven years, has been named president of ...p. Mr. Grossman will continue,to report to Mark M...
...nzastaurin, even tumors that did develop weren,t a... 12 (HealthDay News) -- A drug called enzastaurin ...cer in mice, and tumors that did develop were less...dings, coupled with the fact that the drug appears...
...d CEO, Scott Grisanti, Publishes Letter Outlining ...am , , BETHEL, Conn., Feb. 12 MedClean Technolog...f innovative technology and services for the onsit...s. The letter, which is available on the Company,...
...eb. 12 After Phil Cohen, president of Cleveland-b...nterview last year, he signed on to do three more ... introduced those videos this week via PRN Funding... three featured factoring educational videos are a...
...pels Myths Surrounding Essential Fat , , ST. LOUI...an Heart Association (AHA) concludes that omega-6 ...en part of a healthy eating plan. Omega-6s are ess...on leading to heart disease, the nation,s number o...
... to discuss fourth quarter financial results - , ...pharm Inc. (TSX: DDS; NASDAQ: DDSS ) today annou...ay, February 26 at 8:30 a.m. (ET) to discuss its f...same day. , To access the conference call by telep...
Other Medicine News:Health News:Kevin Grossman Named President of HRmarketer.com 2Health News:Drug Inhibits Colon Cancer in Mice 2Health News:MedClean Technologies Inc. CEO Publishes Letter to Shareholders 2Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 3Health News:Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET) 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: